The Mounjaro 2.5 mg Pen: Starting Dose, Purpose and What the Evidence Says

The 2.5 mg pen is the mandatory starting dose for all Mounjaro treatment — it exists to reduce early side effects, not to produce maximum weight loss.
Each pre-filled KwikPen contains four weekly doses; one pen covers your first month of treatment at this strength.
Titration to higher doses is decided by the prescriber, typically in four-week steps, based on your response and tolerability.
Mounjaro is a dual GIP and GLP-1 receptor agonist — the only licensed weight-loss medicine in the UK that activates both gut-hormone pathways simultaneously.

The Mounjaro 2.5 mg pen is the starting dose of tirzepatide, prescribed at the beginning of treatment to help your body adjust before any therapeutic increase. Every licensed Mounjaro course begins here, regardless of the weight-loss goal. Each pen delivers four once-weekly doses of 2.5 mg tirzepatide via a pre-filled KwikPen. These are prescription-only medicines; a clinician decides whether treatment is appropriate for you, based on your medical history and circumstances.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the 2.5 mg starting dose fits into the full Mounjaro treatment journey

What the trial evidence tells us about starting at 2.5 mg

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity or overweight and at least one weight-related condition. Participants followed a titration schedule that began at 2.5 mg before progressing through higher doses. At the 15 mg maintenance dose over 72 weeks, average body-weight reduction reached around 20–21%. The point is that nobody began at 15 mg. The 2.5 mg starting phase is baked into the evidence base, it is how the drug was studied, and it is how it is licensed.

The NHS tirzepatide medicines page confirms this: treatment starts at the 2.5 mg dose and is increased gradually by your prescriber. Skipping the starting dose or rushing titration is not supported by the trial design. The graduated approach is why gastrointestinal side effects, which are common early on, tend to settle as the body adapts before the next step up.

If you are researching what the 2.5 mg dose involves before speaking to a clinician, that context matters: the evidence for Mounjaro's weight-loss results was built on a process, not a single number.

What the 2.5 mg pen is actually for, and what it is not

The first pen's job is adjustment. At 2.5 mg, tirzepatide begins activating GIP and GLP-1 receptors, but the dose is calibrated for tolerability rather than maximum appetite suppression. Most people notice some reduction in hunger within the first few weeks, but the pronounced appetite changes associated with Mounjaro tend to become more apparent as the dose increases toward the maintenance range.

This is worth setting out plainly because it is one of the questions our prescribers hear most weeks: people worry that 2.5 mg is not working if the effects feel modest. That is the intended picture. The full Mounjaro treatment overview covers what to expect across the dose range, including the licensed strengths from 2.5 mg up to 15 mg.

One practical note: if you order by 12pm on a weekday and are clinically approved, your pen is dispatched the same day. You can read more about how the 2.5 ml pen is designed and used, including its format and handling, before your first delivery arrives. The KwikPen goes in the fridge door when it arrives, refrigerated at 2–8°C, as the patient information leaflet specifies. For the exact storage window at room temperature, always check the leaflet rather than relying on secondary sources.

Mounjaro is not appropriate for everyone. Pregnancy, breastfeeding, and actively trying to conceive are situations where it is not recommended. It is not licensed for anyone under 18. A history of certain conditions, including medullary thyroid carcinoma, requires discussion with the prescriber before treatment can be considered.

Titration: what comes after the 2.5 mg pen

After four weeks at 2.5 mg, the prescriber reviews your progress and tolerance before deciding whether to increase the dose. The licensed UK titration steps are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, each typically held for four weeks before the next step, at the prescriber's discretion.

Not everyone reaches 15 mg. The prescriber's aim is the lowest dose that achieves a meaningful clinical response while remaining well tolerated. NICE's appraisal of tirzepatide, TA1026, notes that continuing treatment is reviewed if less than 5% weight loss is achieved after six months at the highest tolerated dose.

If you are thinking about what the 5 mg pen step involves, or want to understand costs before you commit, there is a separate page covering Mounjaro pricing in the UK that sets out what to expect from private providers. And if you miss a dose during your first month, the guidance on what to do if you miss a Mounjaro dose explains the practical steps without second-guessing your prescriber.

For anyone considering treatment through a regulated route, a free consultation with our prescribers is the starting point, no referral, no waiting list, and a real clinician reviews your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions